Literature DB >> 20640393

[Acute coronary syndrome. A diffuse diagnosis].

F Post1, T Münzel.   

Abstract

Acute coronary syndrome is one of the most common reasons for a presentation in an emergency room. The biggest component of the overall mortality in adults is acute coronary syndrome or in this context its complications. The term "acute coronary syndrome" comprises on one hand 3 entities--unstable angina pectoris, Non-ST-elevation myocardial infarction and ST-elevation myocardial infarction. On the other hand particularly in emergency medicine the term is used as a working diagnosis for patients with unclear, acute chest pain. Although the underlying disease has not changed, especially with the introduction of troponins and the changes of their reference values the concept and importance of acute myocardial infarction has changed. This article emphasises on the current nomenclature and its importance for the adequate diagnosis and treatment are explained.

Entities:  

Mesh:

Year:  2010        PMID: 20640393     DOI: 10.1007/s00108-009-2536-2

Source DB:  PubMed          Journal:  Internist (Berl)        ISSN: 0020-9554            Impact factor:   0.743


  32 in total

1.  Human genetics. To clot or not.

Authors:  A J Fosang; P J Smith
Journal:  Nature       Date:  2001-10-04       Impact factor: 49.962

2.  Angioscopic examination of the coronary arteries: what have we learned?

Authors:  K Mizuno
Journal:  Heart Dis Stroke       Date:  1992 Sep-Oct

3.  COMMIT/CCS-2 studies.

Authors:  Mark Garton
Journal:  Lancet       Date:  2006-08-19       Impact factor: 79.321

4.  Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes.

Authors:  Jean-Pierre Bassand; Christian W Hamm; Diego Ardissino; Eric Boersma; Andrzej Budaj; Francisco Fernández-Avilés; Keith A A Fox; David Hasdai; E Magnus Ohman; Lars Wallentin; William Wijns
Journal:  Eur Heart J       Date:  2007-06-14       Impact factor: 29.983

Review 5.  ACC/AHA expert consensus document. Use of sildenafil (Viagra) in patients with cardiovascular disease. American College of Cardiology/American Heart Association.

Authors:  M D Cheitlin; A M Hutter; R G Brindis; P Ganz; S Kaul; R O Russell; R M Zusman
Journal:  J Am Coll Cardiol       Date:  1999-01       Impact factor: 24.094

6.  Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban.

Authors:  C P Cannon; W S Weintraub; L A Demopoulos; R Vicari; M J Frey; N Lakkis; F J Neumann; D H Robertson; P T DeLucca; P M DiBattiste; C M Gibson; E Braunwald
Journal:  N Engl J Med       Date:  2001-06-21       Impact factor: 91.245

7.  Assessment of the treatment effect of enoxaparin for unstable angina/non-Q-wave myocardial infarction. TIMI 11B-ESSENCE meta-analysis.

Authors:  E M Antman; M Cohen; D Radley; C McCabe; J Rush; J Premmereur; E Braunwald
Journal:  Circulation       Date:  1999-10-12       Impact factor: 29.690

Review 8.  Inflammation in atherosclerosis: from pathophysiology to practice.

Authors:  Peter Libby; Paul M Ridker; Göran K Hansson
Journal:  J Am Coll Cardiol       Date:  2009-12-01       Impact factor: 24.094

9.  Enoxaparin vs unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndromes managed with an intended early invasive strategy: primary results of the SYNERGY randomized trial.

Authors:  James J Ferguson; Robert M Califf; Elliott M Antman; Marc Cohen; Cindy L Grines; Shaun Goodman; Dean J Kereiakes; Anatoly Langer; Kenneth W Mahaffey; Christopher C Nessel; Paul W Armstrong; Alvaro Avezum; Phil Aylward; Richard C Becker; Luigi Biasucci; Steven Borzak; Jacques Col; Marty J Frey; Ed Fry; Dietrich C Gulba; Sema Guneri; Enrique Gurfinkel; Robert Harrington; Judith S Hochman; Neal S Kleiman; Martin B Leon; Jose Luis Lopez-Sendon; Carl J Pepine; Witold Ruzyllo; Steven R Steinhubl; Paul S Teirstein; Luis Toro-Figueroa; Harvey White
Journal:  JAMA       Date:  2004-07-07       Impact factor: 56.272

Review 10.  Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials.

Authors:  Ellen C Keeley; Judith A Boura; Cindy L Grines
Journal:  Lancet       Date:  2003-01-04       Impact factor: 79.321

View more
  2 in total

1.  Cardiac MR enables diagnosis in 90% of patients with acute chest pain, elevated biomarkers and unobstructed coronary arteries.

Authors:  T Emrich; K Emrich; N Abegunewardene; K Oberholzer; C Dueber; T Muenzel; K-F Kreitner
Journal:  Br J Radiol       Date:  2015-03-18       Impact factor: 3.039

2.  Reduce mortality risk above all else: a discrete-choice experiment in acute coronary syndrome patients.

Authors:  Axel C Mühlbacher; Susanne Bethge
Journal:  Pharmacoeconomics       Date:  2015-01       Impact factor: 4.981

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.